Table 3.
Top hits of differences between the non-inflamed tissues from UC patients and non-IBD controls.
Nucleic Acid | Phyla | Family | Fold Change† | p-value |
---|---|---|---|---|
DNA | Proteobacteria | 2.675 | <0.001 | |
DNA | Bacteroidetes | 0.844 | <0.001 | |
DNA | Proteobacteria | Enterobacteriaceae | 4.473 | <0.001 |
DNA | Firmicutes | Peptostreptococcaceae | 4.205 | 0.001 |
DNA | Bacteroidetes | Prevotellaceae | 0.197 | 0.009 |
RNA | Proteobacteria | 2.206 | 0.004 | |
RNA | Firmicutes | Peptostreptococcaceae | 5.669 | <0.001 |
RNA | Proteobacteria | Enterobacteriaceae | 3.861 | 0.001 |
RNA | Bacteroidetes | Prevotellaceae | 0.408 | <0.001 |
†A fold change > 1 indicates a higher abundance in samples from UC patients than in non-IBD patients.